Moxifloxacin for the treatment of pulmonary tuberculosis in children: A single center experience

To report our experience on the safety and tolerability of moxifloxacin for treating children affected by pulmonary TB.

[1]  F. Tritar,et al.  [Management of multidrug-resistant tuberculosis]. , 2015, Revue de pneumologie clinique.

[2]  E. Pontali,et al.  Drug-resistant tuberculosis , 2013, Current opinion in pulmonary medicine.

[3]  C. Doit,et al.  Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases. , 2012, The Pediatric infectious disease journal.

[4]  C. Perez-Velez.  Pediatric tuberculosis: new guidelines and recommendations , 2012, Current opinion in pediatrics.

[5]  I. Kitai,et al.  Drug-resistant tuberculosis: pediatric guidelines. , 2011, The Pediatric infectious disease journal.

[6]  H. S. Schaaf,et al.  Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. , 2011, Paediatric respiratory reviews.

[7]  I. Esposito,et al.  Two Pediatric Cases of Multidrug-Resistant Tuberculosis Treated With Linezolid and Moxifloxacin , 2010, Pediatrics.

[8]  M. Murray,et al.  Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  H. S. Schaaf,et al.  Management of drug-resistant tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  G. Kahlmeter,et al.  Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. , 2010, The Journal of antimicrobial chemotherapy.

[11]  William R Bishai,et al.  Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial , 2009, The Lancet.

[12]  D. Mitchison,et al.  A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  J. Torres,et al.  Severe acute polyarthritis in a child after high doses of moxifloxacin , 2008, Scandinavian journal of infectious diseases.

[14]  Stop Tb Partnership Childhood Tb Subgroup.  Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  M. Rennels,et al.  The Use of Systemic Fluoroquinolones , 2006, Pediatrics.

[16]  C. Daley,et al.  Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  E. Leibovitz.  The use of fluoroquinolones in children , 2006, Current opinion in pediatrics.

[18]  S. Gillespie,et al.  Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. , 2005, The Journal of antimicrobial chemotherapy.

[19]  M. Nahata,et al.  Clinical Use of Fluoroquinolones in Children , 2000, The Annals of pharmacotherapy.

[20]  U. Schaad,et al.  Quinolone arthropathy in animals versus children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Nalin Rastogi,et al.  In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis , 1996, Antimicrobial agents and chemotherapy.

[22]  E. A. Dale,et al.  Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids , 1977 .

[23]  P. Donald,et al.  Paediatric use of second-line anti-tuberculosis agents: a review. , 2012, Tuberculosis.

[24]  F. Marra,et al.  Fluoroquinolones for the Treatment of Pulmonary Tuberculosis , 2012, Drugs.

[25]  S. Squire,et al.  Fluoroquinolones for treating tuberculosis. , 2005, The Cochrane database of systematic reviews.

[26]  Regione Lombardia,et al.  CENTRO NAZIONALE DI EPIDEMIOLOGIA, SORVEGLIANZA E PROMOZIONE DELLA SALUTE , 2005 .